Navigation Links
KFx Medical Corporation Announced Today It Has Received FDA 510k Clearance for Product(s) Used in a Wide Variety of Knee Procedures
Date:5/26/2010

KFx Medical Corporation Announced Today It Has Received FDA 510k Clearance for Product(s) Used in a Wide Variety of Arthroscopic Tenodesis Knee Procedures Such as: ACL, PCL, and Patellofemoral Ligament (MPFL) Reconstruction

(PRWEB) May 26, 2010 -- KFx Medical Corporation announced today it has received FDA 510k clearance for product(s) used in a wide variety of arthroscopic tenodesis knee procedures such as: anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), and Medial Patellofemoral Ligament (MPFL) reconstruction.

KFx Medical received 510k clearance from the Food and Drug Administration for its AppianFx™ product line for soft tissue repair and reconstruction in the knee. “The AppianFx for knee ligament/tissue fixation continues our focus on providing products, with broad intellectual protection, that enable surgeons to more quickly and easily perform complex procedures. This clearance to market our AppianFx family of implants significantly expands the number of surgical procedures for which we provide products to now include all extremities,” indicated Tate Scott, president and CEO of KFx Medical.

The AppianFx line of implants from KFx reattach tissue to bone in shoulder, knee, foot and ankle procedures which combined exceed well over 1 million annual surgical procedures. Product offerings include those that directly place and secure tissue into bone both with and without the use of sutures.

About KFx Medical Corporation

Headquartered in Carlsbad, Calif., KFx Medical Corporation was founded in 2003 to develop products for tissue fixation in a variety of orthopedic surgical procedures performed on the shoulder, knee, foot, and ankle. KFx provides simple systems for orthopedic surgeons focused on sports medicine. The company is privately held — Investors include Alloy Ventures , Charter Life Sciences , Arboretum Ventures , Montreux Equity Partners , and MB Venture Partners .

###

Read the full story at http://www.prweb.com/releases/2010/05/prweb4057154.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. NAMI Medical Director Honored with APA Patient Advocacy Award; Appears in CNN Health and Huffington Post Columns
2. Houston Northwest Medical Center Becomes First Hospital in the Southwest Region Designated a Community of Respect™ Partner
3. An Embryo Mix up Would Involve New York Medical Malpractice Lawyers
4. MxSecure's Electronic Medical Record (EMR) Software, MxChart™, Now iPad Compatible
5. LaVie Administrative Services Continues 1,200 Access Point Aerohive Roll Out to Address Electronic Medical Record Requirements
6. ATMP and Secure-24 Offer Physicians Leadership and Guidance for Electronic Medical Records
7. TransforMED Launches New Service Offering to Accelerate Medical Home Adoption in Small Practices
8. Corporate health program reduces employee CVD medical, hospital costs
9. Medical Devices Driving Up Heart Care Costs
10. Poll finds concerns about pace of medical and health research
11. Manmade antibodies hold biomedical promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... Coppin Insurance Agency, an insurance and financial planning firm ... Cape Coral area, is embarking on a charity drive with the goal of providing ... Harry Chapin Food Bank of Southwest Florida works to provide fresh and nutritious food ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication ... one of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department ... on both sides of the Atlantic with a mechanism to comply with EU data ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... drug in their bodies, a researcher at the Icahn School of Medicine at ... , The study found that when young children are exposed to secondhand marijuana ...
(Date:12/7/2016)... ... December 07, 2016 , ... EnghouseSystems ... purchase price of approximately $17.4 million (net of the cash acquired), subject ... $13.2 million. Headquartered in Barcelona, Spain, Presence is a leading provider of ...
(Date:12/7/2016)... ... 2016 , ... A quote from Dr. Edward Hallowell, host of CRN International’s ... offer a rare glimpse into the mind of those people with ADHD. , Dr. ... author, has described people with ADHD as having “Ferrari engines for a brain, with ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016  Northwest Biotherapeutics (Nasdaq: ... "Company"), a biotechnology company developing DCVax® personalized immune ... the Nasdaq Staff has not accepted the Company,s ... Rules previously reported, and the Company has notified ... Company,s common stock from listing on Nasdaq.  Upon ...
(Date:12/7/2016)... --  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... the ralinepag phase 2 trial.  Ralinepag is an oral, ... the treatment of pulmonary arterial hypertension (PAH). The study ... "This marks an important step in the development of ... our pipeline," said Amit Munshi , Arena,s President ...
(Date:12/7/2016)... Kan. , Dec. 7, 2016   Rx Savings ... West Virginia and its Public Employees Insurance Agency ... members access to their innovative healthcare software, ultimately saving money ... with PEIA and provide its members with access to our ... or a more effective, affordable therapy can be found," says ...
Breaking Medicine Technology: